MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 1, 2016, Pages 10-16

  Yu, Xin ^a   Li, Zheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

MicroRNA; MiRNA; Oncogene; Tongue squamous cell carcinoma; Tumour suppressor gene

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 133A; MICRORNA 133B; MICRORNA 148A; MICRORNA 154; MICRORNA 16; MICRORNA 17 5P; MICRORNA 189; MICRORNA 18B; MICRORNA 195; MICRORNA 19A; MICRORNA 202; MICRORNA 203; MICRORNA 20B; MICRORNA 21; MICRORNA 23A; MICRORNA 26B; MICRORNA 27A; MICRORNA 27B; MICRORNA 31; MICRORNA 320; MICRORNA 342; MICRORNA 451; MICRORNA 494; MICRORNA 513; MICRORNA 519B; MICRORNA 525; MICRORNA 61; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION; HUMAN; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TONGUE CARCINOMA; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RNA INTERFERENCE; SECONDARY; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; PROGNOSIS; RNA INTERFERENCE; TONGUE NEOPLASMS;

EID: 84956585475     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12650     Document Type: Review

References (62)

1. Li J, Huang H, Sun L, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009; 15: 3998-4008.
2. Jung HM, Patel RS, Phillips BL, et al. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions. Mol Biol Cell. 2013; 24: 1638-48, S1-7.
3. Yan B, Fu Q, Lai L, et al. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. Mol Med Rep. 2012; 6: 675-81.
4. Manikandan M, Deva Magendhra Rao AK, Munirajan AK. Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics. J Oral Pathol Med. 2015; 44: 792-800.
5. Zhou X, Huang D, Xue Z, et al. Effect of HIF-1alpha on biological activation of human tongue squamous cell carcinoma SCC-15 cells in vitro. Int J Oncol. 2015; 46: 2346-54.
6. Yan J, Jiang Y, Ye M, et al. The clinical value of lymphatic vessel density, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 expression in patients with oral tongue squamous cell carcinoma. J Cancer Res Ther. 2014; 10: C125-30.
7. Aparna M, Rao L, Kunhikatta V, et al. The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. J Oral Pathol Med. 2015; 44: 345-52.
8. Xie N, Wang C, Liu X, et al. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. J Oral Pathol Med. 2015; 44: 266-72.
9. Hwa JS, Kwon OJ, Park JJ, et al. The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2015; 272: 2953-9.
10. Li HF, Liu YQ, Shen ZJ, et al. Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. Oncol Rep. 2015; 33: 651-60.
11. Riemann M, Knipfer C, Rohde M, et al. Oral squamous cell carcinoma of the tongue - prospective and objective speech evaluation of patients undergoing surgical therapy. Head Neck. 2014; doi:10.1002/hed.23994.
12. Tsai CY, Lai YS, Chen MK. Prediction of lymph node metastasis in T1/T2 tongue squamous cell carcinoma. B-ENT. 2014; 10: 179-84.
13. Yu X, Li Z, Shen J, et al. MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration. PLoS ONE. 2013; 8: e83080.
14. Li Z, Lei H, Luo M, et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer. 2015; 18: 43-54.
15. Li Z, Yu X, Shen J, et al. MicroRNA in intervertebral disc degeneration. Cell Prolif. 2015; 48: 278-83.
16. Li Z, Yu X, Shen J, et al. MicroRNA dysregulation in uveal melanoma: a new player enters the game. Oncotarget. 2015; 6: 4562-8.
17. Yu X, Li Z. MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis. Int J Mol Med. 2014; 34: 923-33.
18. Li M, Yu M, Liu C, et al. miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. Cell Prolif. 2013; 46: 223-31.
19. Li Z, Yu X, Shen J, et al. MicroRNA expression and its clinical implications in Ewing's sarcoma. Cell Prolif. 2015; 48: 1-6.
20. Yu X, Li Z, Liu J. MiRNAs in primary cutaneous lymphomas. Cell Prolif. 2015; 48: 271-7.
21. Zhou J, Song S, Cen J, et al. MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. Oncol Res. 2012; 20: 197-203.
22. Liang J, Zhang Y, Jiang G, et al. MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. Oncol Res. 2013; 21: 83-91.
23. Li H, Yang BB. Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget. 2012; 3: 1653-68.
24. Li Z, Yu X, Wang Y, et al. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget. 2014; 6: 17559-69.
25. Ohdaira H, Sekiguchi M, Miyata K, et al. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif. 2012; 45: 32-8.
26. Li J, You T, Jing J. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Cell Prolif. 2014; 47: 152-60.
27. Bier A, Giladi N, Kronfeld N, et al. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget. 2013; 4: 665-76.
28. Hidaka H, Seki N, Yoshino H, et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget. 2012; 3: 44-57.
29. Ouchida M, Kanzaki H, Ito S, et al. Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach. PLoS ONE. 2012; 7: e44095.
30. Furuta M, Kozaki K, Tanimoto K, et al. The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS ONE. 2013; 8: e60155.
31. Yan K, Gao J, Yang T, et al. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS ONE. 2012; 7: e33778.
32. Wong TS, Liu XB, Chung-Wai Ho A, et al. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer. 2008; 123: 251-7.
33. Liu X, Yu J, Jiang L, et al. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics. 2009; 6: 131-9.
34. Yu ZW, Zhong LP, Ji T, et al. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Oral Oncol. 2010; 46: 317-22.
35. Rentoft M, Fahlen J, Coates PJ, et al. miRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples. Int J Oncol. 2011; 38: 61-9.
36. Sun L, Yao Y, Liu B, et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene. 2012; 31: 432-45.
37. Wong TS, Liu XB, Wong BY, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008; 14: 2588-92.
38. Liu X, Wang A, Heidbreder CE, et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Lett. 2010; 584: 4115-20.
39. Jiang L, Liu X, Chen Z, et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J. 2010; 432: 199-205.
40. Jiang L, Liu X, Kolokythas A, et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell m igration and invasion in tongue squamous cell carcinoma. Int J Cancer. 2010; 127: 505-12.
41. Jiang L, Dai Y, Liu X, et al. Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Hum Genet. 2011; 129: 189-97.
42. Jia LF, Wei SB, Gong K, et al. Prognostic implications of micoRNA miR-195 expression in human tongue squamous cell carcinoma. PLoS ONE. 2013; 8: e56634.
43. Xu JY, Yang LL, Ma C, et al. MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Trop Med. 2013; 6: 743-7.
44. Jia LF, Wei SB, Gan YH, et al. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer. 2014; 135: 2282-93.
45. Kai Y, Peng W, Ling W, et al. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells. Biochem Biophys Res Commun. 2014; 448: 308-14.
46. Lin Z, Sun L, Chen W, et al. miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1. Cancer Sci. 2014; 105: 1288-98.
47. Song KB, Liu WJ, Jia SS. miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI. Int J Clin Exp Med. 2014; 7: 2957-65.
48. Cao J, Guo T, Dong Q, et al. miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism. Oncol Rep. 2015; 33: 974-80.
49. Liu M, Wang J, Huang H, et al. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma. Biochem Biophys Res Commun. 2013; 441: 364-70.
50. Ren W, Wang X, Gao L, et al. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4. Mol Cell Biochem. 2014; 390: 253-62.
51. Fu LL, Zhao X, Xu HL, et al. Identification of microRNA-regulated autophagic pathways in plant lectin-induced cancer cell death. Cell Prolif. 2012; 45: 477-85.
52. Luo X, Dong Z, Chen Y, et al. Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway. Cell Prolif. 2013; 46: 436-46.
53. Lee HK, Finniss S, Cazacu S, et al. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget. 2013; 4: 346-61.
54. Zhu LH, Liu T, Tang H, et al. MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J. 2010; 277: 3726-34.
55. Zhang S, Shan C, Kong G, et al. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene. 2012; 31: 3607-20.
56. Kleinsteuber K, Heesch K, Schattling S, et al. Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T cells and peripheral blood from tuberculosis patients. PLoS ONE. 2013; 8: e61609.
57. Xiong L, Wang F, Huang X, et al. DNA demethylation regulates the expression of miR-210 in neural progenitor cells subjected to hypoxia. FEBS J. 2012; 279: 4318-26.
58. Codo P, Weller M, Meister G, et al. MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape. Oncotarget. 2014; 5: 7651-62.
59. Redova M, Poprach A, Besse A, et al. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol. 2013; 34: 481-91.
60. Kanitz A, Imig J, Dziunycz PJ, et al. The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS ONE. 2012; 7: e49568.
61. Zhu W, He J, Chen D, et al. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS ONE. 2014; 9: e87780.
62. Majid S, Dar AA, Saini S, et al. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS ONE. 2013; 8: e67686.